AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Collaborative care model to facilitate integration of mental healthcare into HIV treatment and prevention services for adolescents and young adults in Bangkok, ThailandView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Real-world effectiveness, safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF} in routine clinical practice in people living with HIV (PLWH}, ChinaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in treatment experienced patients -Asian Real-world ExperienceView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Cost-Effectiveness of DTG/3TC for human immunodeficiency virus (HIV-1) infection treatment in TaiwanView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/T AF) among people living with HIV in a real-world settingView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment-naive adults with HIV-1 infection: 3-year results from the GEMINI studies in participants from Asian centersView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Factors associated with mental health screening preferences among people living with HIV receiving care at a tertiary care hospital in MalaysiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021High rates of depressive symptoms, suicidal ideation, and substance use among adults living with HIV in the Asia-Pacific region.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Sarcopenia in PLWH in Asia: Which definition correlates with health outcomes?View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Preference and ability to perform blood-based versus oral fluidbased HIV self-testing in adolescents and young adults aged 18- 24 years at risk of HIV acquisition in Thailand: a cross-sectional studyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Impact of COVID-19 on HIV testing and care at a university hospital in TaiwanView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Performance of HCV antigen assay in the diagnosis of acute HCV infection among at-risk people living with HIVView Abstract
